Pharma Bro Martin Shkreli Resigns as CEO of Turing Pharmaceuticals After Arrest

Pharma Bro Martin Shkreli Resigns as CEO of Turing Pharmaceuticals After Arrest
Source: Getty Images
Source: Getty Images

Pharmaceutical company Turing announced Friday that Martin Shkreli, infamous for hiking the price of a life-dependent HIV drug by 5,000%, resigned from his position as the chief executive officer of the company after he was arrested Thursday for securities fraud. The company's chairman of the board of directors Ron Tilles will replace Shkreli as interim CEO.

"We wish to thank Martin for helping us build Turing Pharmaceuticals into the dynamic research focused company it is today, and wish him the best in his future endeavors," Turing's statement reads. The FBI arrested Shkreli, 32, on Thursday on the suspicion that he used stock from Retrophin, the biotech company he founded in 2011, to pay off personal debt.

Read More:
° Pharma Bro Martin Shkreli Has Been Arrested for Securities Fraud
° Pharma Bro Martin Shkreli's Arrest Has Twitter Beside Itself Because "Karma's a Bitch"

Here's the full statement from Turing:

"We remain committed to ensuring that all patients have ready and affordable access to Daraprim and Vecamyl," it says in Turing's statement. Daraprim is the HIV medication Shkreli raised the price from $13.50 to $750 in September, a move that sparked widespread public outrage. People on Twitter celebrated his arrest Thursday — actress Debra Messing tweeted "Karma's a bitch," a sentiment plenty of others on social media echoed. 

An investor who requested anonymity told the New York Times on Friday that although his Thursday arrest had nothing to do with his position at Turing, it would be unjustifiable for Shkreli to remain CEO of the company after the accusations. 

Dec. 18, 1:15 p.m. Eastern: This story has been updated.


Get the five stories that will challenge you to rethink the world by signing up for MicCheck Daily.

How much do you trust the information in this article?

Jessica Eggert

Jessica is a staff writer at Mic, covering breaking news. She is based in New York and can be reached at jessica@mic.com.

MORE FROM

Charlie Gard’s parents say they want to take their son home to die

The parents are returning to court to fight for their right to take their son home.

Vatican shuts off historic fountains in the midst of devastating drought

Officials say it's the first time they can recall ever shutting off the Vatican's fountains.

The last baby orca to be born at SeaWorld dies after serious health issues

Kyara was the last baby orca to be born into SeaWorld's controversial breeding program.

President Donald Trump turns Boy Scout Jamboree into campaign rally

The president discussed health care, Hillary Clinton, Obama, big yachts and more to 40,000 Boy Scouts and volunteers

This child kept HIV in remission for 8 years without drugs. Here’s what that really means.

More than eight years after his initial treatment, the child is still in remission.

Charlie Gard’s parents say they want to take their son home to die

The parents are returning to court to fight for their right to take their son home.

Vatican shuts off historic fountains in the midst of devastating drought

Officials say it's the first time they can recall ever shutting off the Vatican's fountains.

The last baby orca to be born at SeaWorld dies after serious health issues

Kyara was the last baby orca to be born into SeaWorld's controversial breeding program.

President Donald Trump turns Boy Scout Jamboree into campaign rally

The president discussed health care, Hillary Clinton, Obama, big yachts and more to 40,000 Boy Scouts and volunteers

This child kept HIV in remission for 8 years without drugs. Here’s what that really means.

More than eight years after his initial treatment, the child is still in remission.